
Endo International Investor Relations Material
Latest events

Q1 2025
Endo International
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Endo International plc
Access all reports
Endo International plc is a specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription products, as well as over-the-counter medications. The company operates in therapeutic areas such as pain management, urology, and women’s health. Endo serves healthcare providers, pharmacies, and patients with a diverse portfolio of medical solutions. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.
Key slides for Endo International plc


Q2 2024
Endo International plc


Q3 2024
Endo International plc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ENDP
Country
🇺🇸 United States